Background
Continuous rather than categorical measures of psychopathology may provide greater statistical power to detect susceptibility loci for schizophrenia. However, it has not been established that the dimensions of schizophrenic symptomatology and personality traits in nonpsychotic individuals share etiological factors. We therefore sought to clarify the relationship between positive and negative symptoms of schizophrenic probands and dimensions of schizotypy in their first-degree relatives.
Methods
In the Roscommon Family Study, we examined the ability of positive and negative symptoms in probands to predict 7 factors of schizotypy in nonpsychotic relatives using regression analysis. These consisted of positive, negative, and avoidant symptoms; odd speech; suspicious behavior; social dysfunction; and symptoms of borderline personality disorder. We examined 3 proband groups: schizophrenia (n = 127); schizophrenia, simple schizophrenia, and schizoaffective disorder (n = 178); and all nonaffective psychoses (n = 216), and their nonpsychotic relatives (n = 309, 477, and 584, respectively).
Results
Positive symptoms in all nonaffective psychoses probands predicted positive schizotypy (β = 0.1972, P = .0004), social dysfunction (β = 0.0719, P = .0489), and borderline personality disorder symptoms (β = 0.1327, P = .0084) in relatives, while negative symptoms predicted negative schizotypy (β = 0.2069, P = .0002), odd speech (β = 0.2592, P = .0001), suspicious behavior (β = 0.2749, P = .0001), and social dysfunction (β = .2398, P = .0002). Proband negative symptoms and borderline personality disorder symptoms in relatives in the schizophrenia, simple schizophrenia, and schizoaffective disorder group were inversely related (β = −0.1185, P = .05).
Conclusions
Positive and negative symptoms in schizophrenia predict corresponding schizotypal symptoms in relatives. This provides evidence that these schizophrenic symptom factors (1) are etiologically distinct from each other and (2) occur on an etiological continuum with their personality-based counterparts.
PSYCHIATRISTS from a variety of theoretical perspectives, including Kraepelin1 and Bleuler,2 have noted that family members of patients with schizophrenia often have odd personality features, including social isolation, poor interpersonal relationships, unusual thought content, and odd speech.3-9 These traits were combined into our current concept of schizotypy by Spitzer et al in DSM-III.10 Despite the familial relationship between schizophrenia and schizotypy and substantial evidence for a genetic basis to schizophrenia,11 the extent to which the dimensions of schizophrenia and schizotypy share familial etiological factors is unknown.
Establishing that normal and disease states represent end points of a single continuum of liability has important implications for understanding the genetic architecture of not only schizophrenia, but other complex disorders as well, such as hypertension and diabetes, where affection is defined quantitatively, not qualitatively. Establishing such a continuum of liability in schizophrenia will inform the methodology of molecular genetic studies, where it has been difficult to define an optimal phenotype.11 Quantitative trait loci analysis may be statistically more powerful than traditional linkage methods in detecting susceptibility genes for complex disorders,12 but its use assumes the genetic continuity of normal and disease states.
Schizophrenic psychopathology is multidimensional and heterogeneous.13,14 Factor analytic studies often result in positive, negative, and disorganization factors.15-20 Like schizophrenia, schizotypy is multidimensional and heterogeneous, and is composed of factors that resemble those of schizophrenia.21-23 Some are composed of attenuated forms of classical positive and negative symptoms. Positive schizotypy comprises ideas of reference, illusions, and magical thinking, while negative schizotypy includes poor rapport, aloofness, and guardedness.21
We know of only one study that has addressed the existence of a single continuum of liability for schizophrenic and schizotypal symptoms, showing that negative symptoms in schizophrenic probands were correlated, at the trend level (P<.10), with negative symptoms in their relatives.24 The correlation was greater than a similar one observed for positive symptoms. This study, however, included ill relatives in the analysis.
To further investigate this question, we examined the relationship between classic positive and negative symptoms of schizophrenic probands and dimensions of schizotypy in their first-degree relatives in the Roscommon Family Study. We hypothesized that positive and negative schizophrenic symptoms in probands would predict, respectively, positive and negative schizotypal symptoms. We also predicted relationships between proband negative symptoms and avoidant schizotypy and social dysfunction, as asociality is a prominent negative symptom,14 and since negative symptoms are robustly related to social dysfunction.25,26
The Roscommon Family Study is an epidemiologically based family study of major mental illness in the west of Ireland. Two groups of index probands were examined: (1) schizophrenic—all cases with a diagnosis of schizophrenia from the population-based Roscommon County Case Register27 (n = 303), and (2) affective—a randomly chosen subsample of the cases from the Case Register with a diagnosis of major affective disorder. Because of budgetary restrictions, 75% of these cases were included (n = 99). Of the schizophrenic probands, 18 had been ascertained through 2 private hospitals cooperating with the registry. We were unable to obtain access to these individuals, reducing the number of schizophrenic probands to 285. An average of 15 years after onset, we attempted to follow up all 384 index probands, of whom 37 were dead, 23 were untraceable, 50 refused interview, and 274 were personally interviewed by 1 of 2 Irish psychiatrists. Medical records were obtained for 359 probands. In cases of incomplete data, collateral histories, from either family members or community nurses, were obtained for an additional 52 index probands. In our judgment, sufficient clinical information was available to render a psychiatric diagnosis in 375 of these cases, of whom 126 individuals (123 from the original schizophrenic group and 3 from the original affective group) met DSM-III-R28 criteria for schizophrenia. These diagnostic reviews were performed by one of us (K.S.K.) or Alan Gruenberg, MD, using a blind best-estimate procedure with demonstrated high interrater reliability.29 Of these 126 subjects, 99 were personally interviewed, and 102 had 1 or more relatives with a personal interview or hospital record.
We attempted to personally interview, blind to proband status, all first-degree relatives, aged 16 years and older and residing in the island of Ireland or central and eastern England, of the index probands and a group of unscreened population controls matched for age and sex. We also attempted to obtain and abstract psychiatric hospital records for all hospitalized relatives. As several individuals and families were ascertained more than once, we used the general proband method, in which all individuals are counted once for each time they are independently ascertained.30
Personal interviews were completed in 86% of living traceable relatives (n = 1753), including 342 relatives of probands meeting DSM-III-R criteria for schizophrenia. Their mean ± SD age was 46 ± 16 years and 49% were male. For an additional 12 relatives of the DSM-III-R schizophrenic probands, only hospital records were available. Herein, we present results on the relatives of probands with a personal interview and/or a hospital record.
The personal interview with probands and relatives was based on the Structured Clinical Interview for DSM-III-R31 diagnoses for Axis I disorders and the Structured Interview for Schizotypy32 for schizophrenia-related Axis II disorders. Blind, best-estimate diagnoses using all available information were also made for all relatives with personal interviews and/or hospital records using DSM-III-R criteria by 2 psychiatrists (K.S.K. or Alan M. Gruenberg, MD). In addition to coding diagnoses, these 2 psychiatrists completed the Major Symptoms of Schizophrenia Scale (MSSS).33 This is an instrument designed for use in a best-estimate procedure that codes key symptom and course features as assessed over the entire course of illness. It was designed to allow the experienced clinician to integrate the relative prominence of clinical features over the entire course of illness. The MSSS contains 9 key symptomatic dimensions: delusions (any), schneiderian delusions, hallucinations, positive thought disorder (such as loosening of associations), catatonic symptoms (including stupor and excitement), depressive symptoms, and manic symptoms. In addition, the MSSS rates chronicity of course and global outcome. All symptom variables were coded on 5-point scales. Details are available on request, but the following general guidelines were adopted for the symptomatic variables: 1, clearly not present; 2, possibly present but subthreshold; 3, clearly present but moderate; 4, clearly present and prominent; and 5, clearly present and severe. The reliability of the MSSS was tested on 47 cases with psychotic illness rated blindly by both psychiatrists. Intraclass correlations for these 11 variables ranged from 0.60 for catatonic symptoms to 0.91 for manic symptoms, with a mean ± SD for all 11 variables of 0.77 ± 0.11.
In this study, we performed analyses using 3 definitions of proband caseness: (1) probands with a DSM-III-R diagnosis of schizophrenia (n = 127); (2) probands with diagnoses of schizophrenia, simple schizophrenia, and schizoaffective disorder (n = 178); (3) probands with any of the above diagnoses as well as delusional disorder, schizophreniform disorder, brief reactive psychosis, and psychosis, not otherwise specified (n = 216). We examined all first-degree relatives of these 3 proband groups, excluding those with diagnoses of schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder, brief reactive psychosis, and psychosis, not otherwise specified (n = 309, 477, and 584, respectively).
A factor analysis was performed by the method of principal components with varimax rotation using the SAS procedure FACTOR34 on the 9 symptoms of the MSSS, selecting factors with an eigenvalue of 1.0 or greater. As outlined previously,35 this yielded the 3 factors: (1) negative—with high loadings on negative thought disorder, affective deterioration, positive thought disorder, and catatonia; (2) positive—with high loadings on schneiderian delusions, any delusions, and hallucinations; and (3) affective—with high loadings on manic and depressive symptoms. As detailed elsewhere,21 a similar factor analysis was performed on all 25 items of the Structured Interview for Schizotypy. This yielded 7 factors: positive, negative, and avoidant symptoms, social dsyfunction, suspicious behavior, and symptoms of borderline personality disorder (BPD).
Missing items were imputed by assigning them the mean score of the items in their respective factor. Subjects missing 50% or more of necessary data were excluded from analysis. All scale scores were transformed into standardized scores with mean of 0 and SD of 1. Regression analyses were performed with positive and negative scores of probands as independent variables and all 7 schizotypy factor–derived scores of relatives as dependent variables. Age and sex of relatives and relationship to proband were entered as covariates. A weighted least squares approach was used, weighting for the number of members per family. Analyses were implemented using the GLM procedure in SAS.34 The results of the above analyses are presented without Bonferroni corrections. We present results using 2-tailed P values.
The standardized regression slopes and P values of all analyses are presented in Table 1. More inclusive definitions of caseness were generally associated with more statistically significant results. Proband negative symptoms predicted more schizotypy factors in relatives. These included the negative factor, odd speech, suspicious behavior, and social dysfunction. Negative symptoms also had an inverse relationship with symptoms of borderline personality disorder (BPD) in the analysis of schizophrenia, simple schizophrenia, and schizoaffective disorder probands. Positive symptoms in probands predicted positive schizotypy, BPD symptoms, and social dysfunction in relatives.
In this study, we examined the hypothesis that positive and negative symptoms of schizophrenia share familial etiological factors with corresponding dimensions of schizotypy by relating symptom scores in psychotic probands with scores on 7 schizotypy factors in their nonpsychotic relatives. Our purpose was to elucidate the etiological lines of demarcation in the schizophrenia spectrum and to further characterize the pathway between familial etiological factors and the expression of clinical phenotype in schizophrenia. Although a previous study of this sample showed that the deficit syndrome was associated with social isolation in relatives,36 this is the first study to show that schizophrenia and schizotypy share familial etiological factors for both their positive and negative dimensions.
The results generally confirmed our hypotheses. Overall, negative symptoms had statistically significant relationships with more schizotypy factors than did positive symptoms. This coheres with the general notion that negative symptoms have greater familial, and possibly genetic, bases than do positive symptoms. Evidence suggesting this is their association with greater family history,37 worse premorbid functioning,38-40 and greater longitudinal stability.41-43 Furthermore, the phenomenological resemblance between positive schizotypal symptoms such as magical thinking and illusions on one hand, and positive schizophrenic symptoms on the other, appears to be less than that between negative symptoms of schizotypy21 and schizophrenia.14
The observed relationships between negative symptoms and negative schizotypy and social dsyfunction have face validity, but those with suspicious behavior, odd speech, and BPD symptoms were unexpected. Suspicious behavior might be explained by possible phenomenological overlap with the negative symptoms asociality and poor rapport.14 Furthermore, one of the items loading on our negative schizotypy factor was guardedness21, which intuitively resembles suspiciousness. Features of BPD, however, such as affective instability, inappropriate anger, and impulsivity, seem opposite to classic negative symptoms,14 which may explain the inverse relationship between them.
We were unable to confirm our hypothesis that negative symptoms would predict avoidant schizotypy in relatives. This was indeed surprising, as asociality is an important negative symptom.14 Our avoidant schizotypy factor, however, while including social isolation, also loaded on the anxiety-related traits hypersensitivity, anxiety, and social anxiety, making an etiological relationship with negative symptoms less intuitively appealing. Furthermore, proband clinical features did not predict anxiety disorders in relatives in a prior study of this sample.35
We did not expect to find an etiological relationship between negative symptoms and odd speech. However, in several factor analyses,44,45 including the one performed on this sample,35 the negative factor loaded on odd speech or disorganization. Furthermore, parents of nonparanoid schizophrenic individuals manifest greater levels of formal thought disorder than do parents of paranoid schizophrenic individuals,46 and this subtype should be associated with lower levels of negative symptoms than are other subtypes, based on its operational definition in DSM-III-R.28
Positive symptoms were significantly related to positive schizotypy, social dysfunction, and BPD symptoms. Social dysfunction had significant relationships with both positive and negative symptoms, which may indicate that it is etiologically related to severity of illness rather than specific symptom dimensions. The relationship with BPD symptoms may be related to the propensity for some patients with BPD to exhibit stress-induced paranoia or other mild psychoticlike symptoms, as operationalized in the DSM-III-R criteria.28
The effect sizes (regression slopes) of the analyses did not change substantially when the definition of proband affection was broadened to include nonschizophrenic psychotic disorders, while significance levels increased substantially. This supports the spectrum concept of schizophrenia—that several disorders share with schizophrenia the same underlying liability.47-50 This was consistent with a previous study of this sample in which the spectrum concept was formally tested by fitting a multiple threshold model to the data.50
Our results indicate that from a familial perspective, the positive and negative dimensions of schizophrenia "breed true" as their attenuated personality-based variants in nonpsychotic individuals. This suggests that the influence of familial etiological factors determining the expression of these symptom dimensions reaches across the boundary of psychotic illness to phenomena currently classified under the rubric of personality. The specificity of the relationships between the positive schizophrenic and schizotypy factors, as well as between the negative schizophrenic and schizotypy factors, further validates the etiological distinctness of some schizophrenic symptom domains, as suggested by sibling resemblance for clinical features.51-57
These results provide validation for quantitative phenotype definition in genetic linkage and association studies. As genes are likely to comprise substantial components of the familial etiological factors shared by the dimensions of schizophrenia and schizotypy, the same genes would presumably be involved in both phenotypes. This strategy may increase the power of such studies by including more "units" of genetic liability to schizophrenia in analysis.12,58
These results should be interpreted in the context of 4 methodological limitations. First, neither the Structured Interview for Schizotypy nor the MSSS examined all possibly relevant signs and symptoms of schizotypy and schizophrenia, respectively. Furthermore, the 2 scales differ in their comprehensiveness, with the Structured Interview for Schizotypy containing many more items than the MSSS. Both the assessment instrument used and the number of items included in factor analysis may have a significant impact on the composition and number of factors extracted. Perhaps the use of other instruments would have led to different relationships between the factors of schizophrenia and schizotypy. Our use of only 2 factors may be an oversimplification of the multifaceted variability of schizophrenic psychopathology, but there is no consensus in the field about the number of dimensions that best represents the full clinical picture of schizophrenia.19 We opted to use positive and negative symptoms because of their historical prominence and their conception in the minds of many clinicians as core illness dimensions.
Second, the use of different covariates may have resulted in different relationships between the factors of schizophrenia and schizotypy. We used age, sex, and relationship to proband. It may be argued that we should have also controlled for social class of the relatives, as this predicted several schizotypy factors.21 However, when this covariate was used in a prior study, it had no impact on the prediction of proband diagnoses of psychotic disorders by schizotypy factors.21
Third, it is not possible to determine whether the results obtained herein are due to genetic as opposed to environmental factors. In addition, an argument made by Kendler et al51 with respect to sibling resemblance for psychotic syndromes may apply here. This would hold that the correlations between relatives as reported here might be due not only to susceptibility genes for schizophrenia but also to genes determining temperament and intellect. Future studies should attempt to partial out these effects.
Fourth, while we tested a hypothesis about primary negative symptoms, or those due to the disease itself, it was not possible to differentiate between these and secondary negative symptoms in probands. Secondary negative symptoms may result from depression, medication-induced parkinsonism, and chronicity.59-61 To differentiate between these and primary negative symptoms, it would have been necessary to perform negative symptom ratings before and after treatment,60 which would be impractical in a genetic-epidemiological sample such as ours. This possible confound may have decreased the effect sizes obtained in the regression analyses, although a recent study showed that while negative symptoms were associated with greater family history, the deficit syndrome was not.62
Accepted for publication February 5, 2001.
This project was largely supported by grants MH41953 and MH54150 from the National Institute of Mental Health, Rockville, Md. Additional support came from the Scottish Rite Benevolent Foundation's Schizophrenia Research Program, Northern Masonic Jurisdiction, United States.
Corresponding author and reprints: Ayman Fanous, MD, Box 980126, Richmond, VA 23298-0126 (e-mail: ahfanous@hsc.vcu.edu).
1.Kraepelin
ETransBarclay
RMTrans Dementia Praecox and Paraphrenia. 8th ed. Huntington, NY Krieger Publishing1971;
2.Bleuler
E Dementia Praecox, or The Group of Schizophrenias. New York, NY International Universities Press1950;
3.Kendler
KS Diagnostic approaches to schizotypal personality disorder: a historical perspective.
Schizophr Bull. 1985;11538- 553
Google ScholarCrossref 4.Kendler
KSMcGuire
MGruenberg
AMO'Hare
ASpellman
MWalsh
D The Roscommon Family Study, III: schizophrenia-related personality disorders in relatives.
Arch Gen Psychiatry. 1993;50781- 788
Google ScholarCrossref 5.Maier
WLichtermann
DMinges
JHeun
R Personality disorders among the relatives of schizophrenia patients.
Schizophr Bull. 1994;20481- 493
Google ScholarCrossref 6.Baron
MGruen
RRainer
JDKane
JAsnis
LLord
S A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia.
Am J Psychiatry. 1985;142447- 455
Google Scholar 7.Silverman
JMSiever
LJHorvath
TBCoccaro
EFKlar
HDavidson
MPinkham
LApter
SHMohs
RCDavis
KL Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders.
Am J Psychiatry. 1993;150435- 442
Google Scholar 8.Katsanis
JIacono
WGBeiser
M Anhedonia and perceptual aberration in first-episode psychotic patients and their relatives.
J Abnorm Psychol. 1990;99202- 206
Google ScholarCrossref 9.Clementz
BAGrove
WMKatsanis
JIacono
WG Psychometric detection of schizotypy: perceptual aberration and physical anhedonia in relatives of schizophrenics.
J Abnorm Psychol. 1991;100607- 612
Google ScholarCrossref 10.Spitzer
RLEndicott
JGibbon
M Crossing the border into borderline personality and borderline schizophrenia: the development of criteria.
Arch Gen Psychiatry. 1979;3617- 24
Google ScholarCrossref 11.Kendler
KS Schizophrenia: genetics. Sadock
BJSadock
VAeds.
Comprehensive Textbook of Psychiatry. Baltimore, Md Williams & Wilkins1999;942- 968
Google Scholar 12.Risch
N Linkage strategies for genetically complex traits, II: the power of affected relative pairs.
Am J Hum Genet. 1990;46229- 241
Google Scholar 13.Cancro
RCLehmann
HE Schizophrenia: clinical features. Sadock
BJSadock
VAeds.
Comprehensive Textbook of Psychiatry Baltimore, Md Williams & Wilkins1999;1169- 1199
Google Scholar 14.Andreasen
NC Negative symptoms in schizophrenia: definition and reliability.
Arch Gen Psychiatry. 1982;39784- 788
Google ScholarCrossref 15.Strauss
JSCarpenter
WT
JrBartko
J The diagnosis and understanding of schizophrenia, part III: speculations on the processes that underlie schizophrenic symptoms and signs.
Schizophr Bull. 1974;1161- 69
Google ScholarCrossref 16.Liddle
PF The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy.
Br J Psychiatry. 1987;151145- 151
Google ScholarCrossref 17.Bilder
RMMukherjee
SRieder
ROPandurangi
AK Symptomatic and neuropsychological components of defect states.
Schizophr Bull. 1985;11409- 419
Google ScholarCrossref 18.Murphy
BMBurke
JGBray
JCWalsh
DKendler
KS An analysis of the clinical features of familial schizophrenia.
Acta Psychiatr Scand. 1994;89421- 427
Google ScholarCrossref 19.Stuart
GWPantelis
CKlimidis
SMinas
IH The three-syndrome model of schizophrenia: meta-analysis of an artefact.
Schizophr Res. 1999;39233- 242
Google ScholarCrossref 20.Lenzenweger
MFDworkin
RH The dimensions of schizophrenia phenomenology: not one or two, at least three, perhaps four.
Br J Psychiatry. 1996;168432- 440
Google ScholarCrossref 21.Kendler
KSMcGuire
MGruenberg
AMWalsh
D Schizotypal symptoms and signs in the Roscommon Family Study: their factor structure and familial relationship with psychotic and affective disorders.
Arch Gen Psychiatry. 1995;52296- 303
Google ScholarCrossref 22.Bergman
AJHarvey
PDMitropoulou
VAronson
AMarder
DSilverman
JTrestman
RSiever
LJ The factor structure of schizotypal symptoms in a clinical population.
Schizophr Bull. 1996;22501- 509
Google ScholarCrossref 23.Gruzelier
JH The factorial structure of schizotypy, part I: affinities with syndromes of schizophrenia.
Schizophr Bull. 1996;22611- 620
Google ScholarCrossref 24.Tsuang
MT Genotypes, phenotypes, and the brain: a search for connections in schizophrenia.
Br J Psychiatry. 1993;163299- 307
Google ScholarCrossref 25.Jackson
HJMinas
IHBurgess
PMJoshua
SDCharisiou
JCampbell
IM Negative symptoms and social skills performance in schizophrenia.
Schizophr Res. 1989;2457- 463
Google ScholarCrossref 26.Bellack
ASMorrison
RLWixted
JTMueser
KT An analysis of social competence in schizophrenia.
Br J Psychiatry. 1990;156809- 818
Google ScholarCrossref 27.Walsh
DO'Hare
ABlake
BHalpenny
JVO'Brien
PF The treated prevalence of mental illness in the Republic of Ireland—the three county case register study.
Psychol Med. 1980;10465- 470
Google ScholarCrossref 28.American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC American Psychiatric Association1987;
29.Kendler
KSMcGuire
MGruenberg
AMO'Hare
ASpellman
MWalsh
D The Roscommon Family Study, I: methods, diagnosis of probands, and risk of schizophrenia in relatives.
Arch Gen Psychiatry. 1993;50527- 540
Google ScholarCrossref 30.Crow
JF Problems of ascertainment in the analysis of family data. Neel
JVShaw
NWSchull
WJeds.
Genetics and the Epidemiology of Chronic Diseases. Washington DC US Dept of Health, Education, and Welfare1965;23- 44
Google Scholar 31.Spitzer
RLWilliams
JBGibbon
M Structured Clinical Interview for DSM-III-R. New York, NY Biometrics Research Dept, New York State Psychiatric Institute1987;
32.Kendler
KSLieberman
JAWalsh
D The Structured Interview for Schizotypy (SIS): a preliminary report.
Schizophr Bull. 1989;15559- 571
Google ScholarCrossref 33.Kendler
KSMcGuire
MGruenberg
AMWalsh
D An epidemiologic, clinical, and family study of simple schizophrenia in County Roscommon, Ireland.
Am J Psychiatry. 1994;15127- 34
Google Scholar 34.SAS Institute, SAS/STAT User's Guide, Version 6. Vols 1 and 2.4th ed. Cary, NC SAS Institute1990;
35.Kendler
KSMcGuire
MGruenberg
AMWalsh
D Clinical heterogeneity in schizophrenia and the pattern of psychopathology in relatives: results from an epidemiologically based family study.
Acta Psychiatr Scand. 1994;89294- 300
Google ScholarCrossref 36.Kirkpatrick
BRoss
DEWalsh
DKarkowski
LKendler
KS Family characteristics of deficit and nondeficit schizophrenia in the Roscommon Family Study.
Schizophr Res. 2000;4557- 64
Google ScholarCrossref 37.Kay
SR Significance of the positive-negative distinction in schizophrenia.
Schizophr Bull. 1990;16635- 652
Google ScholarCrossref 38.Gupta
SRajaprabhakaran
RArndt
SFlaum
MAndreasen
NC Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia.
Schizophr Res. 1995;16189- 197
Google ScholarCrossref 39.Andreasen
NCFlaum
MSwayze
VW
IITyrrell
GArndt
S Positive and negative symptoms in schizophrenia: a critical reappraisal.
Arch Gen Psychiatry. 1990;47615- 621
Google ScholarCrossref 40.Peralta
VCuesta
MJde Leon
J Premorbid personality and positive and negative symptoms in schizophrenia.
Acta Psychiatr Scand. 1991;84336- 339
Google ScholarCrossref 41.Fenton
WSMcGlashan
TH Natural history of schizophrenia subtypes, II: positive and negative symptoms and long-term course.
Arch Gen Psychiatry. 1991;48978- 986
Google ScholarCrossref 42.Pfohl
BWinokur
G The micropsychopathology of hebephrenic/catatonic schizophrenia.
J Nerv Ment Dis. 1983;171296- 300
Google ScholarCrossref 43.Pfohl
BWinokur
G The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics.
Br J Psychiatry. 1982;141567- 572
Google ScholarCrossref 44.Peralta
VCuesta
MJde Leon
J An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model.
Biol Psychiatry. 1994;36726- 736
Google ScholarCrossref 45.Dollfus
SEveritt
B Symptom structure in schizophrenia: two-, three- or four-factor models?
Psychopathology. 1998;31120- 130
Google ScholarCrossref 46.Rund
BRBlakar
RM Schizophrenic patients and their parents: a multimethod design and the findings from an illustrative empirical study of cognitive disorders and communication deviances.
Acta Psychiatr Scand. 1986;74396- 408
Google ScholarCrossref 47.Gershon
ESDeLisi
LEHamovit
JNurnberger
JI
JrMaxwell
MESchreiber
JDauphinais
DDingman
CW
IIGuroff
JJ A controlled family study of chronic psychoses: schizophrenia and schizoaffective disorder.
Arch Gen Psychiatry. 1988;45328- 336
Google ScholarCrossref 48.Faraone
SVTsuang
MT Familial links between schizophrenia and other disorders: application of the multifactorial polygenic model.
Psychiatry. 1988;5137- 47
Google Scholar 49.Kendler
KSMcGuire
MGruenberg
AMSpellman
MO'Hare
AWalsh
D The Roscommon Family Study, II: the risk of nonschizophrenic nonaffective psychoses in relatives.
Arch Gen Psychiatry. 1993;50645- 652
Google ScholarCrossref 50.Kendler
KSNeale
MCWalsh
D Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study.
Am J Psychiatry. 1995;152749- 754
Google Scholar 51.Kendler
KSKarkowski-Shuman
LO'Neill
FAStraub
REMacLean
CJWalsh
D Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: evidence for possible etiologic heterogeneity.
Am J Psychiatry. 1997;154191- 198
Google Scholar 52.Ross
DEKirkpatrick
BKarkowski
LMStraub
REMacLean
CJO'Neill
FACompton
ADMurphy
BWalsh
DKendler
KS Sibling correlation of deficit syndrome in the Irish study of high-density schizophrenia families.
Am J Psychiatry. 2000;1571071- 1076
Google ScholarCrossref 53.Loftus
JDelisi
LECrow
TJ Factor structure and familiality of first-rank symptoms in sibling pairs with schizophrenia and schizoaffective disorder.
Br J Psychiatry. 2000;17715- 19
Google ScholarCrossref 54.Cardno
AGJones
LAMurphy
KCSanders
RDAsherson
POwen
MJMcGuffin
P Sibling pairs with schizophrenia or schizoaffective disorder: associations of subtypes, symptoms and demographic variables.
Psychol Med. 1998;28815- 823
Google ScholarCrossref 55.Loftus
JDeLisi
LECrow
TJ Familial associations of subsyndromes of psychosis in affected sibling pairs with schizophrenia and schizoaffective disorder.
Psychiatry Res. 1998;80101- 111
Google ScholarCrossref 56.DeLisi
LEGoldin
LRMaxwell
MEKazuba
DMGershon
ES Clinical features of illness in siblings with schizophrenia or schizoaffective disorder.
Arch Gen Psychiatry. 1987;44891- 896
Google ScholarCrossref 57.Cardno
AGJones
LAMurphy
KCSanders
RDAsherson
POwen
MJMcGuffin
P Dimensions of psychosis in affected sibling pairs.
Schizophr Bull. 1999;25841- 850
Google ScholarCrossref 58.Brzustowicz
LMHoner
WGChow
EWHogan
JHodgkinson
KBassett
AS Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromsome 6p.
Am J Hum Genet. 1997;611388- 1396
Google ScholarCrossref 59.Carpenter
WT
JrHeinrichs
DWWagman
AMI Deficit and nondeficit forms of schizophrenia: the concept.
Am J Psychiatry. 1988;145578- 583
Google Scholar 60.Miller
DDFlaum
MArndt
SFleming
FAndreasen
NC Effect of antipsychotic withdrawal on negative symptoms in schizophrenia.
Neuropsychopharmacology. 1994;1111- 20
Google ScholarCrossref 61.Kelley
MEvan Kammen
DPAllen
DN Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.
Am J Psychiatry. 1999;156406- 411
Google Scholar 62.Malaspina
DGoetz
RRYale
SBerman
AFriedman
JHTremeau
FPrintz
DAmador
XJohnson
JBrown
AGorman
JM Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome.
Am J Psychiatry. 2000;157994- 1003
Google ScholarCrossref